Global Needle-Free Diabetes Care Market, By Devices Types (Treatment Devices, Diagnostic Devices), Treatment (Oral Insulin, Inhaled Insulin, Insulin Patch, Others), Application (Insulin Delivery, Other), End Users (Diagnostic Centers, Hospitals & Clinics, Other), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028